KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma

Despite curative-intent treatment, most patients with locally advanced esophageal cancer will experience disease recurrence or locoregional progression, highlighting the need for new therapies. Current guidelines recommend definitive chemoradiotherapy in patients ineligible for surgical resection, b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Future Oncol
Autores principales: Shah, Manish A, Bennouna, Jaafar, Doi, Toshihiko, Shen, Lin, Kato, Ken, Adenis, Antoine, Mamon, Harvey J, Moehler, Markus, Fu, Xiaolong, Cho, Byoung Chul, Bordia, Sonal, Bhagia, Pooja, Shih, Chie-Schin, Desai, Anjali, Enzinger, Peter
Formato: Artigo
Lenguaje:Inglês
Publicado: Future Medicine Ltd 2021
Materias:
Clinical Trial Protocol
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7927908/
https://ncbi.nlm.nih.gov/pubmed/33533655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2020-0969
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares